Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport.
about
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerAltered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.Advances in personalized therapy for lung cancer.
P2860
Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Dipyridamole potentiates the i ...... bition of thymidine transport.
@ast
Dipyridamole potentiates the i ...... bition of thymidine transport.
@en
type
label
Dipyridamole potentiates the i ...... bition of thymidine transport.
@ast
Dipyridamole potentiates the i ...... bition of thymidine transport.
@en
prefLabel
Dipyridamole potentiates the i ...... bition of thymidine transport.
@ast
Dipyridamole potentiates the i ...... bition of thymidine transport.
@en
P2093
P2860
P356
P1476
Dipyridamole potentiates the i ...... ibition of thymidine transport
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.1999.1020
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1033983149